- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x GLA- NAG- GAL- FUC: beta-D-galactopyranose-(1-3)-[alpha-L-fucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-alpha-D-galactopyranose
- 1 x NAG- GAL- FUC: beta-D-galactopyranose-(1-3)-[alpha-L-fucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-GAL-FUC.2: 14 residues within 4Å:- Chain A: G.114
- Chain B: N.21, S.22, A.23, G.24, T.45, E.95, D.96, S.97, D.99, D.101, D.104
- Ligands: CA.8, CA.9
5 PLIP interactions:4 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:T.45
- Hydrogen bonds: B:A.23, B:D.96, B:D.99, A:G.114, B:D.99, B:S.22, B:G.24
- Water bridges: B:T.98, B:T.98, B:D.99, B:S.22, B:S.97
- 1 x GAL- NAG- GAL- FUC: beta-D-galactopyranose-(1-3)-[alpha-L-fucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-beta-D-galactopyranose
GAL-NAG-GAL-FUC.3: 13 residues within 4Å:- Chain C: N.21, S.22, A.23, G.24, E.95, D.96, S.97, D.99, D.101, D.104
- Chain D: G.114
- Ligands: CA.11, CA.12
5 PLIP interactions:1 interactions with chain D, 4 interactions with chain C- Hydrogen bonds: D:G.114, C:A.23, C:D.96, C:D.99, C:D.99, C:S.22, C:G.24, C:S.97
- Water bridges: C:T.98, C:T.98, C:S.22
- 8 x CA: CALCIUM ION(Non-covalent)
CA.5: 6 residues within 4Å:- Chain A: E.95, D.99, D.101, D.104
- Ligands: GLA-NAG-GAL-FUC.1, CA.6
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:E.95, A:E.95, A:D.99, A:D.101, A:D.104
CA.6: 7 residues within 4Å:- Chain A: N.21, D.101, N.103, D.104
- Chain B: G.114
- Ligands: GLA-NAG-GAL-FUC.1, CA.5
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Metal complexes: A:N.21, A:D.101, A:D.104, B:G.114
CA.8: 6 residues within 4Å:- Chain B: E.95, D.99, D.101, D.104
- Ligands: NAG-GAL-FUC.2, CA.9
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:E.95, B:E.95, B:D.99, B:D.101, B:D.104
CA.9: 7 residues within 4Å:- Chain A: G.114
- Chain B: N.21, D.101, N.103, D.104
- Ligands: NAG-GAL-FUC.2, CA.8
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain B- Metal complexes: A:G.114, B:N.21, B:D.101, B:D.104
CA.11: 6 residues within 4Å:- Chain C: E.95, D.99, D.101, D.104
- Ligands: GAL-NAG-GAL-FUC.3, CA.12
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:E.95, C:E.95, C:D.99, C:D.101, C:D.104
CA.12: 7 residues within 4Å:- Chain C: N.21, D.101, N.103, D.104
- Chain D: G.114
- Ligands: GAL-NAG-GAL-FUC.3, CA.11
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain D- Metal complexes: C:N.21, C:D.101, C:D.104, D:G.114
CA.14: 6 residues within 4Å:- Chain D: E.95, D.99, D.101, D.104
- Ligands: GLA-NAG-GAL-FUC.4, CA.15
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:E.95, D:E.95, D:D.99, D:D.101, D:D.104
CA.15: 7 residues within 4Å:- Chain C: G.114
- Chain D: N.21, D.101, N.103, D.104
- Ligands: GLA-NAG-GAL-FUC.4, CA.14
4 PLIP interactions:3 interactions with chain D, 1 interactions with chain C- Metal complexes: D:N.21, D:D.101, D:D.104, C:G.114
- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.7: 3 residues within 4Å:- Chain A: S.44, N.46, A.48
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.44, A:N.46
- Water bridges: A:T.45, A:N.46
SO4.10: 2 residues within 4Å:- Chain B: G.58, G.59
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:N.11, B:G.59
- Water bridges: B:N.33, B:G.60
SO4.13: 4 residues within 4Å:- Chain C: V.32, N.33, G.58, G.59
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.33, C:G.59
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sommer, R. et al., The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery. Chem Sci (2016)
- Release Date
- 2016-05-25
- Peptides
- LECB: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x GLA- NAG- GAL- FUC: beta-D-galactopyranose-(1-3)-[alpha-L-fucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-alpha-D-galactopyranose
- 1 x NAG- GAL- FUC: beta-D-galactopyranose-(1-3)-[alpha-L-fucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x GAL- NAG- GAL- FUC: beta-D-galactopyranose-(1-3)-[alpha-L-fucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-beta-D-galactopyranose
- 8 x CA: CALCIUM ION(Non-covalent)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sommer, R. et al., The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery. Chem Sci (2016)
- Release Date
- 2016-05-25
- Peptides
- LECB: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D